Reading Time: 2 minutes
Listen to this article
Doctors May Soon Be Banned From Prescribing Brands
Doctors May Soon Be Banned From Prescribing Brands

Doctors May Soon Be Banned From Prescribing Brands

The Supreme Court of India recently emphasized that all doctors across the country should be required to prescribe generic medicines instead of branded ones. This statement came during the hearing of a Public Interest Litigation (PIL) focused on stopping unethical marketing practices by pharmaceutical companies.

The Issue: Unethical Promotion of Branded Drugs

The PIL was filed by the Federation of Medical & Sales Representatives Associations of India (FMSRAI) and other parties. It raised concerns that pharmaceutical companies spend huge amounts of money on marketing and promotions to influence doctors into prescribing more expensive branded drugs. These practices, the petitioners say, prioritize profit over patients’ well-being.

What Are Generic Medicines?

Generic medicines are drugs that have the same chemical composition, strength, and effectiveness as branded medicines but are much more affordable. They offer a cost-effective option for patients without compromising quality.

Doctors Under Pressure

According to the plea, doctors are often targeted through promotional strategies like gifts, sponsorships, and incentives in exchange for writing more prescriptions for specific brands. This, in turn, leads to unnecessary costs for patients.

A Call for Stronger Regulation

The Supreme Court noted that the current rules regulating such practices are only voluntary and not strictly enforced. The petitioners are seeking legal directions to make these rules binding, under the Right to Health guaranteed by Article 21 of the Indian Constitution.

Rajasthan Sets an Example

During the hearing, the court referred to Rajasthan, where doctors are now officially instructed to prescribe only generic medicines. The bench, led by Justice Vikram Nath and joined by Justices Sanjay Karol and Sandeep Mehta, stated that such steps should be implemented nationwide.

Conclusion

The case has been scheduled for further hearing in July. The Supreme Court’s observation marks a significant step towards promoting ethical medical practices and ensuring that quality healthcare remains accessible and affordable to all.

SourceInputs from various media Sources 

Priya Bairagi

Reviewed by Dr Aarti Nehra (MBBS, MMST)

I’m a pharmacist with a strong background in health sciences. I hold a BSc from Delhi University and a pharmacy degree from PDM University. I write articles and daily health news while interviewing doctors to bring you the latest insights. In my free time, you’ll find me at the gym or lost in a sci-fi novel.

Scroll to Top